Acucela Inc.
Records under this name other than the patents Acucela Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 73 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,314,152 | Methods and compositions for treating ophthalmic conditions with retinyl derivatives Lapsed on the fee record Ended Nov 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2020 | From the USPTO record |
| US 8,299,307 | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Oct 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2020 | From the USPTO record |
| US 9,464,033 | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Oct 11, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 11, 2020 | From the USPTO record |
| US 7,432,307 | Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation Lapsed on the fee record Ended Oct 7, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2020 | From the USPTO record |
| US 9,458,088 | Alkoxy compounds for disease treatment Lapsed on the fee record Ended Oct 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2020 | From the USPTO record |
| US 9,452,153 | Amine derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Sep 27, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 27, 2020 | From the USPTO record |
| US 9,447,078 | Substituted heterocyclic compounds for disease treatment Lapsed on the fee record Ended Sep 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | From the USPTO record |
| US 9,421,210 | Styrenyl derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Aug 23, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 23, 2020 | From the USPTO record |
| US 9,314,467 | Styrenyl derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Apr 19, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2020 | From the USPTO record |
| US 8,076,516 | Amine derivative compounds for treating ophthalmic diseases and disorders Lapsed on the fee record Ended Dec 13, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2019 | From the USPTO record |